Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a common nasal spray could help prevent infection. This randomized ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Azelastine lowered the risk for SARS-CoV-2 infection vs.

The trial, led by Professor Robert Bals, Director of the Department of Internal Medicine V at Saarland University Medical Center and Professor of Internal Medicine at Saarland University, divided the ...

Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19. Participants in the trial were also 71% less likely to catch the common cold than ...

A research team at Saarland University has demonstrated in a clinical study that a widely used anti-allergy nasal spray containing the active ingredient azelastine can significantly reduce the risk of ...

Share on Pinterest A new trial shows that a common nasal spray may help lower the risk of contracting COVID-19 and other respiratory illnesses. Professional Studio Images/Getty Images Researchers say ...

Every winter, I prepare for my clinic schedule to fill up with patients experiencing runny noses, coughs, and fevers caused by viruses, such as rhinoviruses, influenza, and COVID-19. I also prepare ...